BioLionaire Scientist-Volume 2: CRISPR EMPIRE: How Gene Editing Becomes the Next Billion-Dollar Frontier (Paperback) (ISBN-13: 9798274461788)

CRISPR Empire continues the BioLionaire Scientist series by examining how clustered regularly interspaced short palindromic repeats (CRISPR) evolved from a bacterial immune curiosity into one of the most disruptive platforms in biotechnology history.

This volume connects molecular precision with venture-scale execution. It explores how CRISPR-Cas systems transitioned from genome-editing tools to therapeutic pipelines, agricultural innovations, synthetic biology engines, and multibillion-dollar biotech companies.

Rather than presenting gene editing as a single breakthrough, the book analyzes the layered architecture behind platform dominance: mechanism discovery, programmable design, delivery challenges, regulatory risk, intellectual property battles, manufacturing realities, and translational funding strategy.

Written for scientists, translational researchers, and biotech builders, this volume moves from core CRISPR biology to competitive landscapes and capital formation - demonstrating how gene editing becomes not only a technology, but an empire.

This volume is written for graduate students, postdoctoral researchers, clinician-scientists, synthetic biology innovators, translational research teams, and biotechnology entrepreneurs seeking a serious understanding of genome-editing strategy. It is also appropriate for academic libraries, biotech incubators, and institutions training the next generation of platform builders.

Part I - The Science of Editing Life
Chapter 1 - The CRISPR Code
Chapter 2 - The Tools of Precision
Chapter 3 - From Lab to Life

Part II - CRISPR in Action
Chapter 4 - CRISPR in Cancer
Chapter 5 - Editing Beyond Cancer
Chapter 6 - The Diagnostic Revolution

Part III - The Business of Editing
Chapter 7 - The CRISPR Companies
Chapter 8 - Patent Wars - The CRISPR Empire
Chapter 9 - Ethics, Equity, and the Human Future

Part IV - The Next Frontier
Chapter 10 - CRISPR 3.0: The Intelligent Genome
Chapter 11 - CRISPR 3.0 Founder-Ready Playbook

Appendices
Appendix A - One Page Protocols
Appendix B - Investor Lens

Glossary
Index
Companies Discussed in this Volume
Essential Reading

Available Editions

- Kindle eBook (Full-Color Edition)
- Paperback - Black & White Reading Edition
- Premium Hardcover - Full-Color Flagship & Collector's Edition